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A 48-lead precordial ST-segment map, consisting of six rows of eight leads, was performed in all 12 patients one hour prior to the start of the infusion, using an ECG standardization of 1 mV = 20 mm.`0 In six patients demonstrating anterior precordial ST-segment changes, serial 16-lead recordings were made with each of the subsequent hemodynamic measurements. ST-segment changes recorded serially in two of these six rows had previously been found in a group of 20 anterior infarctions to be representative of ST changes recorded in the 48 leads. A 16-lead system consisting of two rows (rows D and E) were, therefore, used for the remainder of the study with the chest marked for exact repositioning. The sum of the ST elevations or depressions in the 16 leads was determined and this sum defined as 1 ST.
The group of eight untreated patients with anterior precordial ST-segment changes underwent serial 16 lead ST-segment recordings at time intervals comparable to mapping studies in the nitroglycerin treated patients.
Results
The hemodynamic measurements and derived parameters for the 12 patients are presented in table 3. Left ventricular filling pressure fell from a mean of 22 ± 2 mm Hg during the control period to a mean of 12 ± 1 mm Hg at the time of maximal preload lowering effect of nitroglycerin. Thirty minutes postinfusion, the left ventricular filling pressure rose to 18 ± 2 mm Hg ( fig. 2 ). This decrease in left ventricular filling pressure and subsequent increase were significant (P < 0.001). The left ventricular filling pressure thirty minutes post infusion was also significantly lower than the control value (P < 0.01). While the exact time of maximal reduction of left ventricular filling pressure varied between 10 and 30 minutes after beginning the infusion in the 12 patients studied, the mean left ventricular filling pressure at a fixed time after the onset of infusion, e.g., 30 minutes, was 13 + 1 mm Hg, which is only slightly higher than the value for maximum drug effect. This filling pressure was equally different from control (P < 0.001). The left ventricular filling pressure fell significantly in all 12 patients (mean 42.8%, range 20 to 68%).
The mean arterial pressure fell from a mean of 102 ± 3 mm Hg during the control period to 95 ± 4 mm Hg at the time of maximum drug effect and returned to 102 ± 5 mm Hg 30 minutes post infusion ( fig. 2 ). These changes in mean arterial pressure were significant (P < 0.05). The mean arterial pressure decreased with nitroglycerin infusion in nine of 12 patients (mean 10.3%) and rose in the remaining three patients (mean 9.3%). A significant increase in heart rate was not noted in the 12 patients, with the maximum increase in rate being only 7%.
The cardiac index and stroke work index did not change significantly. In figure 3, that, at the dose levels used in this study, nitroglycerin has a predominant effect on the venous system compared to its effect on the arterial system. Diuretics such as furosemide which produce venous pooling and a significant fall in preload result in a decrease in stroke volume.3 Conversely, afterload lowering would be expected to produce an increase in stroke volume."1 In this study, cardiac index, heart rate, and therefore, stroke volume did not change significantly, suggesting that there were compensatory changes in the two opposite effects of lowering preload and afterload. The administration of intravenous nitroglycerin at comparable infusion rates to normal subjects, likewise, produced no rise in cardiac output. 12 Gold et al. demonstrated an improvement in stroke volume with a reduction in left ventricular filling pressure with administration of sublingual nitroglycerin to patients with left ventricular failure This marked degree of afterload lowering was associated with improvement in left ventricular function as manifested by a significant fall in left ventricular filling pressure with a significant increase in cardiac output.5 In the present study intravenous nitroglycerin allowed the lowering of left ventricular filling pressure and the improvement in left ventricular function without a large decrease in mean arterial pressure, thus, minimizing the decrease in coronary perfusion. In fact, in three patients in the present study, a small increase in mean arterial pressure occurred with a significant fall in left ventricular filling pressure. Since an index of infarct size was not reported using nitroprusside or phentolamine infusion, the effect of the greater decrease in coronary perfusion pressure on borderline ischemic myocardium remains unknown. At the dose level used in this study, the reduction of left ventricular filling pressure is similar to that which follows the administration of a diuretic but with the added advantages of reversibility and more precise control of hemodynamic effects. Furthermore, the decrease in preload with nitroglycerin is associated with an increase rather than a decrease in left ventricular function, as has been noted to follow diuretic therapy. 3 The mechanism of action of intravenous nitroglycerin in improving left ventricular function is still a subject of speculation. The 16 Precordial ST mapping studies in the present study suggest similar beneficial effects on 2 ST and thus on the extent of instantaneous myocardial ischemia. All six patients undergoing serial mapping demonstrated improvement of the ST-segment abnormalities. While it is possible that part of this decrease in 2 ST could be accounted for by a gradual decrease in ST segment changes noted in untreated patients, it is noteworthy that 2 ST did not increase during nitroglycerin infusion, an effect which might have resulted from a reduction in coronary perfusion pressure. Both this study and the previous study in animals16 suggest that nitroglycerin may indeed have the effect of decreasing infarct size by improving perfusion to and/or decreasing oxygen demands in the borderline ischemic areas surrounding the central zone of infarction. Since nitroglycerin appears to improve left ventricular function and also to decrease the extent of myocardial ischemia, longer infusion of intravenous nitroglycerin may act to preserve borderline ischemic myocardium and thus reduce infarct size.
